Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on September 28, 2015, inter alia, transacted the following business:Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to Shri JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI (ICDR) Regulation 2009. In terms of their issue the warrants are convertible... Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors at their Meeting held on September 04, 2015, inter alia, transacted the following business:1. The Board of Directors have appointed Mr. Brijmohan M Dhoot who is an existing non Executive Director of the Company as the Whole Time Director of the Company w.e.f. September 05, 2015.... Outcome of AGM
Mangalam Drugs & Organics Ltd has informed BSE that the 42nd Annual General Meeting (AGM) of the Company was held on September 03, 2015. Fixes Book Closure for AGM
Mangalam Drugs & Organics Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 28, 2015 to September 03, 2015 (both days inclusive) for the purpose of 42nd Annual General Meeting (AGM) of the Company to be held on September 03, 2015.Further, the members holding shares either in physical form or in dematerialized form, as on the cut-off date of August 27, 2015, may cast their... Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors at their Meeting held on August 06, 2015, at a Shorter Notice, interalia transacted the following business:1. Approved the Shorter Notice of Board Meeting.2. Approved the proposal for fresh issue of upto 26,50,000 Warrants at Rs.65/- each, on preferential basis to Shri. J B Pharma LLP, an entity forming part of the promoter group, subject to the approval of... Board Meeting on August 06, 2015
Mangalam Drugs & Organics Ltd has informed BSE that a meeting of the Board of Directors of the Company, at shorter notice is proposed to be held on August 06, 2015, inter alia, to consider and approve the issue of such number of Warrants or other securities convertible into equity shares or other securities convertible into equity shares on preferential basis to Shri.JB Pharma LLP, ("Promoter" or "Proposed Allottee") subject to the approval of the... Financial Results & Limited Review for June 30, 2015 (Standalone)
Mangalam Drugs & Organics Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015. Closure of Trading Window
Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on August 04, 2015, inter alia, to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2015.Further, Company had adopted revised Code of Conduct for Prevention of Insider Trading with effect from May 14, 2015, in accordance with the amended Securities and Exchange Board of India (Prohibition... Shareholding Pattern For June 30, 2015
Mangalam Drugs & Organics Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ipca Laboratories Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011